Insider Trading - LEE KENNETH B JR

Real time insider trading transaction history:

  1. Insiders must file a Form 4 covering their trades within two business days.
  2. Section 16 prohibits insiders from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
    "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
    - Peter Lynch
    What is insider trading>>
    Time period:
    Insider Trading Transactions for LEE KENNETH B JR

    Common stock purchase or sale:
    Transaction
    Date
    Reported
    DateTime
    Company Symbol Insider
    Relationship
    Shares
    Traded
    Average
    Price
    Total
    Amount
    Shares
    Owned
    Filing
    2016-11-14
    Purchase
    2016-11-15
    5:43 pm
    Aralez Pharmaceuticals Inc. ARLZ LEE KENNETH B JR
    Director
    1,000 $4.95 $4,950 90,452
    (Direct)
    View
    2017-01-17
    Sale
    2017-01-19
    5:53 pm
    Clearside Biomedical Inc. CLSD Hatteras Venture Advisors III LLC
    Hatteras Ventures Partners III LP
    Hatteras Venture Affiliates III Lp
    Crumpler John
    INGRAM ROBERT ALEXANDER
    LEE KENNETH B JR
    Reed Douglas MD
    Thorp Clay
    10% Owner
    25,301 $8.625 $218,222 1,757,719
    (Indirect)
    View
    2017-01-17
    Sale
    2017-01-19
    7:31 pm
    Clearside Biomedical Inc. CLSD Hatteras Venture Advisors IV SBIC LLC
    Hatteras Venture Partners IV SBIC LP
    Crumpler John
    INGRAM ROBERT ALEXANDER
    LEE KENNETH B JR
    Reed Douglas MD
    Thorp Clay
    10% Owner
    29,656 $8.6251 $255,785 2,060,514
    (Indirect)
    View
    2017-03-15
    Purchase
    2017-03-17
    4:17 pm
    Aralez Pharmaceuticals Inc. ARLZ LEE KENNETH B JR
    Director
    5,000 $2.5237 $12,618 95,452
    (Direct)
    View
    2017-05-22
    Purchase
    2017-05-24
    8:18 pm
    G1 Therapeutics Inc. GTHX Thorp Clay
    Hatteras Venture Advisors IV SBIC LLC
    Hatteras Venture Partners IV SBIC LP
    Crumpler John
    INGRAM ROBERT ALEXANDER
    LEE KENNETH B JR
    Reed Douglas MD
    10% Owner
    133,333 $15 $1,999,995 3,861,797
    (Indirect)
    View
    2018-05-21
    Sale
    2018-05-23
    8:46 pm
    G1 Therapeutics Inc. GTHX Thorp Clay
    Hatteras Venture Advisors IV SBIC LLC
    Hatteras Venture Partners IV SBIC LP
    INGRAM ROBERT ALEXANDER
    Crumpler John
    LEE KENNETH B JR
    Reed Douglas MD
    10% Owner
    37,500 $51.11 $1,916,678 4,037,711
    (Indirect)
    View
    2018-05-30
    Sale
    2018-06-01
    6:22 pm
    G1 Therapeutics Inc. GTHX Thorp Clay
    Hatteras Venture Advisors IV SBIC LLC
    Hatteras Venture Partners IV SBIC LP
    INGRAM ROBERT ALEXANDER
    Crumpler John
    LEE KENNETH B JR
    Reed Douglas MD
    10% Owner
    800,000 $48 $38,400,000 3,237,711
    (Indirect)
    View
    2018-10-22
    Purchase
    2018-10-24
    4:18 pm
    PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
    Hatteras Ventures Partners III LP
    Hatteras Venture Affiliates III Lp
    Hatteras Venture Partners I LP
    Catalysta Ventures LLC
    Venture Capital Multiplier Fund
    INGRAM ROBERT ALEXANDER
    LEE KENNETH B JR
    Reed Douglas MD
    Crumpler John
    10% Owner
    300,000 $5 $1,500,000 416,481
    (Indirect)
    View
    2019-11-18
    Purchase
    2019-11-18
    4:14 pm
    BIOCRYST PHARMACEUTICALS INC BCRX LEE KENNETH B JR
    Director
    5,000 $1.45 $7,250 15,252
    (Direct)
    View
    2021-06-11
    Purchase
    2021-06-15
    4:26 pm
    EYENOVIA Inc EYEN LEE KENNETH B JR
    Director
    6,000 $5.4187 $32,512 25,359
    (Direct)
    View
    2021-09-13
    Sale
    2021-09-15
    4:26 pm
    BIOCRYST PHARMACEUTICALS INC BCRX LEE KENNETH B JR
    Director
    6,000 $15.35 $92,100 24,252
    (Direct)
    View

    Stock options: Exercise, Award, Grant, Conversion
    Transaction
    Date
    Reported
    DateTime
    Exercisable
    Expiration
    Company Symnbol Insider
    Relationship
    Shares
    Traded
    Conversion
    Price
    Shares
    Owned
    Filing
    2017-05-11
    Option Award
    2017-05-12
    9:51 pm
    N/A
    N/A
    Aralez Pharmaceuticals Inc. ARLZ LEE KENNETH B JR
    Director
    7,500 $0 102,952
    (Direct)
    View
    2017-05-11
    Option Award
    2017-05-12
    9:51 pm
    N/A
    2027-05-11
    Aralez Pharmaceuticals Inc. ARLZ LEE KENNETH B JR
    Director
    15,000 $0 15,000
    (Direct)
    View
    2017-05-22
    Conversion
    2017-05-24
    8:18 pm
    N/A
    N/A
    G1 Therapeutics Inc. GTHX Thorp Clay
    Hatteras Venture Advisors IV SBIC LLC
    Hatteras Venture Partners IV SBIC LP
    Crumpler John
    INGRAM ROBERT ALEXANDER
    LEE KENNETH B JR
    Reed Douglas MD
    10% Owner
    3,728,464 $0 3,728,464
    (Indirect)
    View
    2017-05-22
    Conversion
    2017-05-24
    8:18 pm
    N/A
    N/A
    G1 Therapeutics Inc. GTHX Thorp Clay
    Hatteras Venture Advisors IV SBIC LLC
    Hatteras Venture Partners IV SBIC LP
    Crumpler John
    INGRAM ROBERT ALEXANDER
    LEE KENNETH B JR
    Reed Douglas MD
    10% Owner
    212,419 $0 212,419
    (Indirect)
    View
    2017-05-22
    Conversion
    2017-05-24
    8:18 pm
    N/A
    N/A
    G1 Therapeutics Inc. GTHX Thorp Clay
    Hatteras Venture Advisors IV SBIC LLC
    Hatteras Venture Partners IV SBIC LP
    Crumpler John
    INGRAM ROBERT ALEXANDER
    LEE KENNETH B JR
    Reed Douglas MD
    10% Owner
    99,513 $0 99,513
    (Indirect)
    View
    2017-05-22
    Conversion
    2017-05-24
    8:18 pm
    N/A
    N/A
    G1 Therapeutics Inc. GTHX Thorp Clay
    Hatteras Venture Advisors IV SBIC LLC
    Hatteras Venture Partners IV SBIC LP
    Crumpler John
    INGRAM ROBERT ALEXANDER
    LEE KENNETH B JR
    Reed Douglas MD
    10% Owner
    1,318,681 $0 0
    (Indirect)
    View
    2017-05-22
    Conversion
    2017-05-24
    8:18 pm
    N/A
    N/A
    G1 Therapeutics Inc. GTHX Thorp Clay
    Hatteras Venture Advisors IV SBIC LLC
    Hatteras Venture Partners IV SBIC LP
    Crumpler John
    INGRAM ROBERT ALEXANDER
    LEE KENNETH B JR
    Reed Douglas MD
    10% Owner
    6,568,527 $0 0
    (Indirect)
    View
    2017-05-22
    Conversion
    2017-05-24
    8:18 pm
    N/A
    N/A
    G1 Therapeutics Inc. GTHX Thorp Clay
    Hatteras Venture Advisors IV SBIC LLC
    Hatteras Venture Partners IV SBIC LP
    Crumpler John
    INGRAM ROBERT ALEXANDER
    LEE KENNETH B JR
    Reed Douglas MD
    10% Owner
    2,584,959 $0 0
    (Indirect)
    View
    2017-05-22
    Conversion
    2017-05-24
    8:18 pm
    N/A
    N/A
    G1 Therapeutics Inc. GTHX Thorp Clay
    Hatteras Venture Advisors IV SBIC LLC
    Hatteras Venture Partners IV SBIC LP
    Crumpler John
    INGRAM ROBERT ALEXANDER
    LEE KENNETH B JR
    Reed Douglas MD
    10% Owner
    1,009,693 $0 0
    (Indirect)
    View
    2017-05-24
    Option Award
    2017-05-25
    11:53 am
    2017-06-24
    2027-05-24
    BIOCRYST PHARMACEUTICALS INC BCRX LEE KENNETH B JR
    Director
    30,000 $0 30,000
    (Direct)
    View
    2017-11-30
    Other
    2017-12-04
    5:01 pm
    N/A
    N/A
    G1 Therapeutics Inc. GTHX Thorp Clay
    Hatteras Venture Advisors IV SBIC LLC
    Hatteras Venture Partners IV SBIC LP
    INGRAM ROBERT ALEXANDER
    Crumpler John
    LEE KENNETH B JR
    Reed Douglas MD
    10% Owner
    99,513 $0 4,074,216
    (Indirect)
    View
    2017-11-30
    Other
    2017-12-04
    5:01 pm
    N/A
    N/A
    G1 Therapeutics Inc. GTHX Thorp Clay
    Hatteras Venture Advisors IV SBIC LLC
    Hatteras Venture Partners IV SBIC LP
    INGRAM ROBERT ALEXANDER
    Crumpler John
    LEE KENNETH B JR
    Reed Douglas MD
    10% Owner
    995 $0 4,075,211
    (Indirect)
    View
    2018-06-20
    Option Award
    2018-06-22
    09:40 am
    2018-07-20
    2028-06-20
    BIOCRYST PHARMACEUTICALS INC BCRX LEE KENNETH B JR
    Director
    30,000 $0 30,000
    (Direct)
    View
    2018-07-24
    Option Award
    2018-07-26
    6:12 pm
    N/A
    N/A
    EYENOVIA Inc EYEN LEE KENNETH B JR
    Director
    4,033 $0 4,033
    (Direct)
    View
    2018-07-24
    Option Award
    2018-07-26
    6:12 pm
    N/A
    2028-07-24
    EYENOVIA Inc EYEN LEE KENNETH B JR
    Director
    4,465 $0 4,465
    (Direct)
    View
    2018-10-22
    Conversion
    2018-10-24
    4:18 pm
    N/A
    N/A
    PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
    Hatteras Ventures Partners III LP
    Hatteras Venture Affiliates III Lp
    Hatteras Venture Partners I LP
    Catalysta Ventures LLC
    Venture Capital Multiplier Fund
    INGRAM ROBERT ALEXANDER
    LEE KENNETH B JR
    Reed Douglas MD
    Crumpler John
    10% Owner
    52,690 $0 52,690
    (Indirect)
    View
    2018-10-22
    Conversion
    2018-10-24
    4:18 pm
    N/A
    N/A
    PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
    Hatteras Ventures Partners III LP
    Hatteras Venture Affiliates III Lp
    Hatteras Venture Partners I LP
    Catalysta Ventures LLC
    Venture Capital Multiplier Fund
    INGRAM ROBERT ALEXANDER
    LEE KENNETH B JR
    Reed Douglas MD
    Crumpler John
    10% Owner
    1,683,420 $0 1,683,420
    (Indirect)
    View
    2018-10-22
    Conversion
    2018-10-24
    4:18 pm
    N/A
    N/A
    PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
    Hatteras Ventures Partners III LP
    Hatteras Venture Affiliates III Lp
    Hatteras Venture Partners I LP
    Catalysta Ventures LLC
    Venture Capital Multiplier Fund
    INGRAM ROBERT ALEXANDER
    LEE KENNETH B JR
    Reed Douglas MD
    Crumpler John
    10% Owner
    150,612 $0 150,612
    (Indirect)
    View
    2018-10-22
    Conversion
    2018-10-24
    4:18 pm
    N/A
    N/A
    PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
    Hatteras Ventures Partners III LP
    Hatteras Venture Affiliates III Lp
    Hatteras Venture Partners I LP
    Catalysta Ventures LLC
    Venture Capital Multiplier Fund
    INGRAM ROBERT ALEXANDER
    LEE KENNETH B JR
    Reed Douglas MD
    Crumpler John
    10% Owner
    4,846 $0 4,846
    (Indirect)
    View
    2018-10-22
    Conversion
    2018-10-24
    4:18 pm
    N/A
    N/A
    PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
    Hatteras Ventures Partners III LP
    Hatteras Venture Affiliates III Lp
    Hatteras Venture Partners I LP
    Catalysta Ventures LLC
    Venture Capital Multiplier Fund
    INGRAM ROBERT ALEXANDER
    LEE KENNETH B JR
    Reed Douglas MD
    Crumpler John
    10% Owner
    266,481 $0 266,481
    (Indirect)
    View
    2018-10-22
    Exercise
    2018-10-24
    4:18 pm
    N/A
    N/A
    PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
    Hatteras Ventures Partners III LP
    Hatteras Venture Affiliates III Lp
    Hatteras Venture Partners I LP
    Catalysta Ventures LLC
    Venture Capital Multiplier Fund
    INGRAM ROBERT ALEXANDER
    LEE KENNETH B JR
    Reed Douglas MD
    Crumpler John
    10% Owner
    19,061 $0 0
    (Indirect)
    View
    2018-10-22
    Exercise
    2018-10-24
    4:18 pm
    N/A
    N/A
    PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
    Hatteras Ventures Partners III LP
    Hatteras Venture Affiliates III Lp
    Hatteras Venture Partners I LP
    Catalysta Ventures LLC
    Venture Capital Multiplier Fund
    INGRAM ROBERT ALEXANDER
    LEE KENNETH B JR
    Reed Douglas MD
    Crumpler John
    10% Owner
    19,061 $0.12 1,045,222
    (Indirect)
    View
    2018-10-22
    Sale
    2018-10-24
    4:18 pm
    N/A
    N/A
    PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
    Hatteras Ventures Partners III LP
    Hatteras Venture Affiliates III Lp
    Hatteras Venture Partners I LP
    Catalysta Ventures LLC
    Venture Capital Multiplier Fund
    INGRAM ROBERT ALEXANDER
    LEE KENNETH B JR
    Reed Douglas MD
    Crumpler John
    10% Owner
    458 $5 1,044,764
    (Indirect)
    View
    2018-10-22
    Exercise
    2018-10-24
    4:18 pm
    N/A
    N/A
    PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
    Hatteras Ventures Partners III LP
    Hatteras Venture Affiliates III Lp
    Hatteras Venture Partners I LP
    Catalysta Ventures LLC
    Venture Capital Multiplier Fund
    INGRAM ROBERT ALEXANDER
    LEE KENNETH B JR
    Reed Douglas MD
    Crumpler John
    10% Owner
    1,731 $0 0
    (Indirect)
    View
    2018-10-22
    Exercise
    2018-10-24
    4:18 pm
    N/A
    N/A
    PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
    Hatteras Ventures Partners III LP
    Hatteras Venture Affiliates III Lp
    Hatteras Venture Partners I LP
    Catalysta Ventures LLC
    Venture Capital Multiplier Fund
    INGRAM ROBERT ALEXANDER
    LEE KENNETH B JR
    Reed Douglas MD
    Crumpler John
    10% Owner
    1,731 $0.12 94,916
    (Indirect)
    View
    2018-10-22
    Sale
    2018-10-24
    4:18 pm
    N/A
    N/A
    PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
    Hatteras Ventures Partners III LP
    Hatteras Venture Affiliates III Lp
    Hatteras Venture Partners I LP
    Catalysta Ventures LLC
    Venture Capital Multiplier Fund
    INGRAM ROBERT ALEXANDER
    LEE KENNETH B JR
    Reed Douglas MD
    Crumpler John
    10% Owner
    42 $5 94,874
    (Indirect)
    View
    2018-10-22
    Exercise
    2018-10-24
    4:18 pm
    N/A
    N/A
    PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
    Hatteras Ventures Partners III LP
    Hatteras Venture Affiliates III Lp
    Hatteras Venture Partners I LP
    Catalysta Ventures LLC
    Venture Capital Multiplier Fund
    INGRAM ROBERT ALEXANDER
    LEE KENNETH B JR
    Reed Douglas MD
    Crumpler John
    10% Owner
    47,458 $0 0
    (Indirect)
    View
    2018-10-22
    Exercise
    2018-10-24
    4:18 pm
    N/A
    N/A
    PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
    Hatteras Ventures Partners III LP
    Hatteras Venture Affiliates III Lp
    Hatteras Venture Partners I LP
    Catalysta Ventures LLC
    Venture Capital Multiplier Fund
    INGRAM ROBERT ALEXANDER
    LEE KENNETH B JR
    Reed Douglas MD
    Crumpler John
    10% Owner
    47,458 $0.12 150,459
    (Indirect)
    View
    2018-10-22
    Sale
    2018-10-24
    4:18 pm
    N/A
    N/A
    PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
    Hatteras Ventures Partners III LP
    Hatteras Venture Affiliates III Lp
    Hatteras Venture Partners I LP
    Catalysta Ventures LLC
    Venture Capital Multiplier Fund
    INGRAM ROBERT ALEXANDER
    LEE KENNETH B JR
    Reed Douglas MD
    Crumpler John
    10% Owner
    1,139 $5 149,320
    (Indirect)
    View
    2018-10-22
    Exercise
    2018-10-24
    4:18 pm
    N/A
    N/A
    PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
    Hatteras Ventures Partners III LP
    Hatteras Venture Affiliates III Lp
    Hatteras Venture Partners I LP
    Catalysta Ventures LLC
    Venture Capital Multiplier Fund
    INGRAM ROBERT ALEXANDER
    LEE KENNETH B JR
    Reed Douglas MD
    Crumpler John
    10% Owner
    4,309 $0 0
    (Indirect)
    View
    2018-10-22
    Exercise
    2018-10-24
    4:18 pm
    N/A
    N/A
    PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
    Hatteras Ventures Partners III LP
    Hatteras Venture Affiliates III Lp
    Hatteras Venture Partners I LP
    Catalysta Ventures LLC
    Venture Capital Multiplier Fund
    INGRAM ROBERT ALEXANDER
    LEE KENNETH B JR
    Reed Douglas MD
    Crumpler John
    10% Owner
    4,309 $0.12 13,662
    (Indirect)
    View
    2018-10-22
    Sale
    2018-10-24
    4:18 pm
    N/A
    N/A
    PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
    Hatteras Ventures Partners III LP
    Hatteras Venture Affiliates III Lp
    Hatteras Venture Partners I LP
    Catalysta Ventures LLC
    Venture Capital Multiplier Fund
    INGRAM ROBERT ALEXANDER
    LEE KENNETH B JR
    Reed Douglas MD
    Crumpler John
    10% Owner
    104 $5 13,558
    (Indirect)
    View
    2018-10-22
    Exercise
    2018-10-24
    4:18 pm
    N/A
    N/A
    PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
    Hatteras Ventures Partners III LP
    Hatteras Venture Affiliates III Lp
    Hatteras Venture Partners I LP
    Catalysta Ventures LLC
    Venture Capital Multiplier Fund
    INGRAM ROBERT ALEXANDER
    LEE KENNETH B JR
    Reed Douglas MD
    Crumpler John
    10% Owner
    41,414 $0 0
    (Indirect)
    View
    2018-10-22
    Exercise
    2018-10-24
    4:18 pm
    N/A
    N/A
    PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
    Hatteras Ventures Partners III LP
    Hatteras Venture Affiliates III Lp
    Hatteras Venture Partners I LP
    Catalysta Ventures LLC
    Venture Capital Multiplier Fund
    INGRAM ROBERT ALEXANDER
    LEE KENNETH B JR
    Reed Douglas MD
    Crumpler John
    10% Owner
    41,414 $0.12 41,414
    (Indirect)
    View
    2018-10-22
    Sale
    2018-10-24
    4:18 pm
    N/A
    N/A
    PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
    Hatteras Ventures Partners III LP
    Hatteras Venture Affiliates III Lp
    Hatteras Venture Partners I LP
    Catalysta Ventures LLC
    Venture Capital Multiplier Fund
    INGRAM ROBERT ALEXANDER
    LEE KENNETH B JR
    Reed Douglas MD
    Crumpler John
    10% Owner
    994 $5 40,420
    (Indirect)
    View
    2018-10-22
    Conversion
    2018-10-24
    4:18 pm
    N/A
    N/A
    PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
    Hatteras Ventures Partners III LP
    Hatteras Venture Affiliates III Lp
    Hatteras Venture Partners I LP
    Catalysta Ventures LLC
    Venture Capital Multiplier Fund
    INGRAM ROBERT ALEXANDER
    LEE KENNETH B JR
    Reed Douglas MD
    Crumpler John
    10% Owner
    52,690 $0 0
    (Indirect)
    View
    2018-10-22
    Conversion
    2018-10-24
    4:18 pm
    N/A
    N/A
    PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
    Hatteras Ventures Partners III LP
    Hatteras Venture Affiliates III Lp
    Hatteras Venture Partners I LP
    Catalysta Ventures LLC
    Venture Capital Multiplier Fund
    INGRAM ROBERT ALEXANDER
    LEE KENNETH B JR
    Reed Douglas MD
    Crumpler John
    10% Owner
    42,530 $0 0
    (Indirect)
    View
    2018-10-22
    Conversion
    2018-10-24
    4:18 pm
    N/A
    N/A
    PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
    Hatteras Ventures Partners III LP
    Hatteras Venture Affiliates III Lp
    Hatteras Venture Partners I LP
    Catalysta Ventures LLC
    Venture Capital Multiplier Fund
    INGRAM ROBERT ALEXANDER
    LEE KENNETH B JR
    Reed Douglas MD
    Crumpler John
    10% Owner
    3,862 $0 0
    (Indirect)
    View
    2018-10-22
    Conversion
    2018-10-24
    4:18 pm
    N/A
    N/A
    PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
    Hatteras Ventures Partners III LP
    Hatteras Venture Affiliates III Lp
    Hatteras Venture Partners I LP
    Catalysta Ventures LLC
    Venture Capital Multiplier Fund
    INGRAM ROBERT ALEXANDER
    LEE KENNETH B JR
    Reed Douglas MD
    Crumpler John
    10% Owner
    4,846 $0 0
    (Indirect)
    View
    2018-10-22
    Conversion
    2018-10-24
    4:18 pm
    N/A
    N/A
    PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
    Hatteras Ventures Partners III LP
    Hatteras Venture Affiliates III Lp
    Hatteras Venture Partners I LP
    Catalysta Ventures LLC
    Venture Capital Multiplier Fund
    INGRAM ROBERT ALEXANDER
    LEE KENNETH B JR
    Reed Douglas MD
    Crumpler John
    10% Owner
    174,699 $0 0
    (Indirect)
    View
    2018-10-22
    Conversion
    2018-10-24
    4:18 pm
    N/A
    N/A
    PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
    Hatteras Ventures Partners III LP
    Hatteras Venture Affiliates III Lp
    Hatteras Venture Partners I LP
    Catalysta Ventures LLC
    Venture Capital Multiplier Fund
    INGRAM ROBERT ALEXANDER
    LEE KENNETH B JR
    Reed Douglas MD
    Crumpler John
    10% Owner
    13,609 $0 0
    (Indirect)
    View
    2018-10-22
    Conversion
    2018-10-24
    4:18 pm
    N/A
    N/A
    PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
    Hatteras Ventures Partners III LP
    Hatteras Venture Affiliates III Lp
    Hatteras Venture Partners I LP
    Catalysta Ventures LLC
    Venture Capital Multiplier Fund
    INGRAM ROBERT ALEXANDER
    LEE KENNETH B JR
    Reed Douglas MD
    Crumpler John
    10% Owner
    1,044,764 $0 0
    (Indirect)
    View
    2018-10-22
    Conversion
    2018-10-24
    4:18 pm
    N/A
    N/A
    PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
    Hatteras Ventures Partners III LP
    Hatteras Venture Affiliates III Lp
    Hatteras Venture Partners I LP
    Catalysta Ventures LLC
    Venture Capital Multiplier Fund
    INGRAM ROBERT ALEXANDER
    LEE KENNETH B JR
    Reed Douglas MD
    Crumpler John
    10% Owner
    94,874 $0 0
    (Indirect)
    View
    2018-10-22
    Conversion
    2018-10-24
    4:18 pm
    N/A
    N/A
    PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
    Hatteras Ventures Partners III LP
    Hatteras Venture Affiliates III Lp
    Hatteras Venture Partners I LP
    Catalysta Ventures LLC
    Venture Capital Multiplier Fund
    INGRAM ROBERT ALEXANDER
    LEE KENNETH B JR
    Reed Douglas MD
    Crumpler John
    10% Owner
    149,320 $0 0
    (Indirect)
    View
    2018-10-22
    Conversion
    2018-10-24
    4:18 pm
    N/A
    N/A
    PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
    Hatteras Ventures Partners III LP
    Hatteras Venture Affiliates III Lp
    Hatteras Venture Partners I LP
    Catalysta Ventures LLC
    Venture Capital Multiplier Fund
    INGRAM ROBERT ALEXANDER
    LEE KENNETH B JR
    Reed Douglas MD
    Crumpler John
    10% Owner
    13,558 $0 0
    (Indirect)
    View
    2018-10-22
    Conversion
    2018-10-24
    4:18 pm
    N/A
    N/A
    PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
    Hatteras Ventures Partners III LP
    Hatteras Venture Affiliates III Lp
    Hatteras Venture Partners I LP
    Catalysta Ventures LLC
    Venture Capital Multiplier Fund
    INGRAM ROBERT ALEXANDER
    LEE KENNETH B JR
    Reed Douglas MD
    Crumpler John
    10% Owner
    40,420 $0 0
    (Indirect)
    View
    2018-10-22
    Conversion
    2018-10-24
    4:18 pm
    N/A
    N/A
    PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
    Hatteras Ventures Partners III LP
    Hatteras Venture Affiliates III Lp
    Hatteras Venture Partners I LP
    Catalysta Ventures LLC
    Venture Capital Multiplier Fund
    INGRAM ROBERT ALEXANDER
    LEE KENNETH B JR
    Reed Douglas MD
    Crumpler John
    10% Owner
    272,107 $0 0
    (Indirect)
    View
    2018-10-22
    Conversion
    2018-10-24
    4:18 pm
    N/A
    N/A
    PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
    Hatteras Ventures Partners III LP
    Hatteras Venture Affiliates III Lp
    Hatteras Venture Partners I LP
    Catalysta Ventures LLC
    Venture Capital Multiplier Fund
    INGRAM ROBERT ALEXANDER
    LEE KENNETH B JR
    Reed Douglas MD
    Crumpler John
    10% Owner
    24,709 $0 0
    (Indirect)
    View
    2018-10-22
    Conversion
    2018-10-24
    4:18 pm
    N/A
    N/A
    PhaseBio Pharmaceuticals Inc PHAS Hatteras Venture Advisors III LLC
    Hatteras Ventures Partners III LP
    Hatteras Venture Affiliates III Lp
    Hatteras Venture Partners I LP
    Catalysta Ventures LLC
    Venture Capital Multiplier Fund
    INGRAM ROBERT ALEXANDER
    LEE KENNETH B JR
    Reed Douglas MD
    Crumpler John
    10% Owner
    226,061 $0 0
    (Indirect)
    View
    2019-05-29
    Option Award
    2019-05-31
    4:23 pm
    2020-05-29
    2029-05-29
    BIOCRYST PHARMACEUTICALS INC BCRX LEE KENNETH B JR
    Director
    30,000 $0 30,000
    (Direct)
    View
    2019-08-16
    Option Award
    2019-08-20
    5:21 pm
    N/A
    N/A
    EYENOVIA Inc EYEN LEE KENNETH B JR
    Director
    8,038 $0 12,071
    (Direct)
    View
    2019-08-16
    Option Award
    2019-08-20
    5:21 pm
    N/A
    2029-08-16
    EYENOVIA Inc EYEN LEE KENNETH B JR
    Director
    9,057 $0 9,057
    (Direct)
    View
    2020-05-12
    Option Award
    2020-05-14
    4:31 pm
    2021-05-12
    2030-05-12
    BIOCRYST PHARMACEUTICALS INC BCRX LEE KENNETH B JR
    Director
    40,000 $0 40,000
    (Direct)
    View
    2020-09-11
    Option Award
    2020-09-15
    4:17 pm
    N/A
    N/A
    EYENOVIA Inc EYEN LEE KENNETH B JR
    Director
    7,288 $0 19,359
    (Direct)
    View
    2020-09-11
    Option Award
    2020-09-15
    4:17 pm
    N/A
    2030-09-11
    EYENOVIA Inc EYEN LEE KENNETH B JR
    Director
    9,820 $0 9,820
    (Direct)
    View
    2021-05-25
    Option Award
    2021-05-27
    4:33 pm
    2022-05-25
    2031-05-25
    BIOCRYST PHARMACEUTICALS INC BCRX LEE KENNETH B JR
    Director
    40,000 $0 40,000
    (Direct)
    View
    2021-09-13
    Exercise
    2021-09-15
    4:26 pm
    N/A
    N/A
    BIOCRYST PHARMACEUTICALS INC BCRX LEE KENNETH B JR
    Director
    15,000 $3.22 30,252
    (Direct)
    View
    2021-09-13
    Exercise
    2021-09-15
    4:26 pm
    2012-06-23
    2022-05-23
    BIOCRYST PHARMACEUTICALS INC BCRX LEE KENNETH B JR
    Director
    15,000 $0 0
    (Direct)
    View